Key terms
About COEP
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest COEP news
No recent press releases are available for COEP
COEP Financials
Key terms
Ad Feedback
COEP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
COEP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range